What if you invested $1,000 in Gilead Sciences in 2010? (Inflation-Adjusted)
GILD · Healthcare · Adjusted to 2026 dollars using BLS CPI-U data
View nominal (non-adjusted) versionGilead Sciences turned $1,000 into $7,858 between 2010 and today. Impressive on paper, but inflation over that span came to 53% (BLS CPI-U). Adjusted for that erosion in purchasing power, your real gain in constant 2010 dollars is $5,136, which works out to a +10.4% annualized real growth rate over 17 years.
Nominal final value
$7,858
+685.8% total return
Real value (2010 dollars)
$5,136
+413.6% real total return
Real annualized return
+10.4%
vs. +13.3% nominal annualized
Year-by-Year (Inflation-Adjusted)
$1,000 in Gilead Sciences since 2010, values in constant 2010 dollars
| Year | Nominal Value | Real Value (2010 $) |
|---|---|---|
| 2010 | $1,000 | $1,000 |
| 2011 | $795 | $764 |
| 2012 | $1,012 | $953 |
| 2013 | $1,635 | $1,506 |
| 2014 | $3,342 | $3,036 |
| 2015 | $4,343 | $3,946 |
| 2016 | $3,480 | $3,116 |
| 2017 | $3,108 | $2,722 |
| 2018 | $3,700 | $3,143 |
| 2019 | $3,189 | $2,647 |
| 2020 | $2,989 | $2,442 |
| 2021 | $3,229 | $2,511 |
| 2022 | $3,525 | $2,511 |
| 2023 | $4,505 | $3,091 |
| 2024 | $4,362 | $2,908 |
| 2025 | $5,639 | $3,686 |
| 2026 | $8,466 | $5,533 |
Inflation adjustment uses BLS CPI-U annual data, deflated to 2026 dollars. Nominal stock data from Yahoo Finance (split-adjusted closing prices). Real values are expressed in constant 2010 purchasing-power dollars. For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. See our methodology and full disclaimer.